Common Contracts
3 similar Agreement and Plan of Merger contracts by ARMO BioSciences, Inc., Daegis Inc., Dusa Pharmaceuticals Inc
AGREEMENT AND PLAN OF MERGER dated as of May 9, 2018, among ELI LILLY AND COMPANY, BLUEGILL ACQUISITION CORPORATION and ARMO BIOSCIENCES, INC.Agreement and Plan of Merger • May 10th, 2018 • ARMO BioSciences, Inc. • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER dated as of May 9, 2018 (this “Agreement”), among Eli Lilly and Company, an Indiana corporation (“Parent”), Bluegill Acquisition Corporation, a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Parent, and ARMO BioSciences, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER by and among DAEGIS INC., OPEN TEXT CORPORATION and COMPANY D MERGER SUB INC. October 8, 2015Agreement and Plan of Merger • October 14th, 2015 • Daegis Inc. • Services-prepackaged software • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated October 8, 2015, is entered into by and among DAEGIS INC., a Delaware corporation (the “Company”), OPEN TEXT CORPORATION, a Canadian corporation (“Parent”), and COMPANY D MERGER SUB INC., a Delaware corporation and an indirect wholly-owned subsidiary of Parent (“Merger Sub”).
AGREEMENT AND PLAN OF MERGER DATED AS OF NOVEMBER 8, 2012 BY AND AMONG SUN PHARMACEUTICAL INDUSTRIES LIMITED MERGER SUB AND DUSA PHARMACEUTICALS, INC.Agreement and Plan of Merger • November 8th, 2012 • Dusa Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
Agreement and Plan of Merger (this “Agreement”), dated as of November 8, 2012, among SUN PHARMACEUTICAL INDUSTRIES LIMITED, a corporation organized under the laws of India (“Parent”), Caraco Acquisition Corporation, a New Jersey corporation and indirect wholly-owned subsidiary of Parent (“Merger Sub”), and DUSA PHARMACEUTICALS, INC., a New Jersey corporation (the “Company”). Capitalized terms not otherwise defined herein shall have the meaning set forth in Exhibit A attached hereto.
